oa SA Pharmaceutical Journal - Onbrez Breezhaler® capsules (150 µg indacaterol maleate) : new product focus

Volume 81, Issue 7
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Onbrez Breezhaler® capsules are indicated as maintenance bronchodilator treatment for airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).1 Each capsule of Onbrez Breezhaler® for inhalation contains the indacaterol maleate equivalent of 150 µg indacaterol and 24.8 mg lactose.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error